Search details
1.
Clonal Deletion of Tumor-Specific T Cells by Interferon-γ Confers Therapeutic Resistance to Combination Immune Checkpoint Blockade.
Immunity
; 50(2): 477-492.e8, 2019 02 19.
Article
in English
| MEDLINE | ID: mdl-30737146
2.
Metastatic melanoma to small bowel: metastasectomy is supported in the era of immunotherapy and checkpoint inhibitors.
World J Surg Oncol
; 22(1): 77, 2024 Mar 11.
Article
in English
| MEDLINE | ID: mdl-38468341
3.
Mechanisms of Cardiovascular Toxicities Associated With Immunotherapies.
Circ Res
; 128(11): 1780-1801, 2021 05 28.
Article
in English
| MEDLINE | ID: mdl-33934609
4.
Loneliness and symptom burden in oncology patients during the COVID-19 pandemic.
Cancer
; 127(17): 3246-3253, 2021 09 01.
Article
in English
| MEDLINE | ID: mdl-33905528
5.
Mechanisms and clinical manifestations of cardiovascular toxicities associated with immune checkpoint inhibitors.
Clin Sci (Lond)
; 135(5): 703-724, 2021 03 12.
Article
in English
| MEDLINE | ID: mdl-33686402
6.
Oncology patients' perceptions of and experiences with COVID-19.
Support Care Cancer
; 29(4): 1941-1950, 2021 Apr.
Article
in English
| MEDLINE | ID: mdl-32809060
7.
Tumor Immune Profiling-Based Neoadjuvant Immunotherapy for Locally Advanced Melanoma.
Ann Surg Oncol
; 27(11): 4122-4130, 2020 Oct.
Article
in English
| MEDLINE | ID: mdl-32488521
8.
PTCH1 Mutation in a Patient With Metastatic Undifferentiated Carcinoma With Clear Cell Change.
J Natl Compr Canc Netw
; 17(7): 778-783, 2019 07 01.
Article
in English
| MEDLINE | ID: mdl-31319387
9.
Obstacles to improving outcomes in the treatment of uveal melanoma.
Cancer
; 124(13): 2693-2703, 2018 07 01.
Article
in English
| MEDLINE | ID: mdl-29579316
10.
Evaluation of clinicopathological factors in PD-1 response: derivation and validation of a prediction scale for response to PD-1 monotherapy.
Br J Cancer
; 116(9): 1141-1147, 2017 Apr 25.
Article
in English
| MEDLINE | ID: mdl-28324889
11.
Clinical outcomes in metastatic uveal melanoma treated with PD-1 and PD-L1 antibodies.
Cancer
; 122(21): 3344-3353, 2016 Nov 15.
Article
in English
| MEDLINE | ID: mdl-27533448
12.
The efficacy of anti-PD-1 agents in acral and mucosal melanoma.
Cancer
; 122(21): 3354-3362, 2016 Nov 15.
Article
in English
| MEDLINE | ID: mdl-27533633
13.
Targeted DNA Sequencing of Cutaneous Melanoma Identifies Prognostic and Predictive Alterations.
Cancers (Basel)
; 16(7)2024 Mar 29.
Article
in English
| MEDLINE | ID: mdl-38611025
14.
POLARIS: A phase 2 trial of encorafenib plus binimetinib evaluating high-dose and standard-dose regimens in patients with BRAF V600-mutant melanoma with brain metastasis.
Neurooncol Adv
; 6(1): vdae033, 2024.
Article
in English
| MEDLINE | ID: mdl-38725995
15.
Mutational Status and Clinical Outcomes Following Systemic Therapy with or without Focal Radiation for Resected Melanoma Brain Metastases.
World Neurosurg
; 170: e514-e519, 2023 Feb.
Article
in English
| MEDLINE | ID: mdl-36400359
16.
Risk Factors for a Higher Symptom Burden in Patients With Cancer During the COVID-19 Pandemic.
Oncol Nurs Forum
; 50(5): 647-664, 2023 08 17.
Article
in English
| MEDLINE | ID: mdl-37677766
17.
Systemic Therapy for Melanoma: ASCO Guideline Update.
J Clin Oncol
; 41(30): 4794-4820, 2023 10 20.
Article
in English
| MEDLINE | ID: mdl-37579248
18.
Re-induction ipilimumab following acquired resistance to combination ipilimumab and anti-PD-1 therapy.
Eur J Cancer
; 153: 213-222, 2021 08.
Article
in English
| MEDLINE | ID: mdl-34214936
19.
Single-cell analyses identify circulating anti-tumor CD8 T cells and markers for their enrichment.
J Exp Med
; 218(4)2021 04 05.
Article
in English
| MEDLINE | ID: mdl-33651880
20.
Multidisciplinary Management of Cancer During Pregnancy.
JCO Oncol Pract
; 16(9): 545-557, 2020 09.
Article
in English
| MEDLINE | ID: mdl-32910882